Cargando…
PB2159: CHARACTERIZATION OF THE IMMUNE RESPONSE DEVELOPED IN PATIENTS WITH MULTIPLE MYELOMA AFTER RECEIVING TWO DOSES OF THE VACCINE AGAINST SARS-COV-2
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428916/ http://dx.doi.org/10.1097/01.HS9.0000975396.12745.cc |
| _version_ | 1785090585273565184 |
|---|---|
| author | Perez, Laura Solera, Miriam Corona, Magdalena Torres, Montserrat Casado, Guiomar Sánchez-Menéndez, Clara Zurdo, Alejandro Garcia, Javier Murciano, Maria Aranzazu Pérez, Maria Teresa Gutierrez, Valentin Garcia Coiras, Maria Teresa Mora, Sara Rodríguez |
| author_facet | Perez, Laura Solera, Miriam Corona, Magdalena Torres, Montserrat Casado, Guiomar Sánchez-Menéndez, Clara Zurdo, Alejandro Garcia, Javier Murciano, Maria Aranzazu Pérez, Maria Teresa Gutierrez, Valentin Garcia Coiras, Maria Teresa Mora, Sara Rodríguez |
| author_sort | Perez, Laura |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428916 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104289162023-08-17 PB2159: CHARACTERIZATION OF THE IMMUNE RESPONSE DEVELOPED IN PATIENTS WITH MULTIPLE MYELOMA AFTER RECEIVING TWO DOSES OF THE VACCINE AGAINST SARS-COV-2 Perez, Laura Solera, Miriam Corona, Magdalena Torres, Montserrat Casado, Guiomar Sánchez-Menéndez, Clara Zurdo, Alejandro Garcia, Javier Murciano, Maria Aranzazu Pérez, Maria Teresa Gutierrez, Valentin Garcia Coiras, Maria Teresa Mora, Sara Rodríguez Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428916/ http://dx.doi.org/10.1097/01.HS9.0000975396.12745.cc Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Perez, Laura Solera, Miriam Corona, Magdalena Torres, Montserrat Casado, Guiomar Sánchez-Menéndez, Clara Zurdo, Alejandro Garcia, Javier Murciano, Maria Aranzazu Pérez, Maria Teresa Gutierrez, Valentin Garcia Coiras, Maria Teresa Mora, Sara Rodríguez PB2159: CHARACTERIZATION OF THE IMMUNE RESPONSE DEVELOPED IN PATIENTS WITH MULTIPLE MYELOMA AFTER RECEIVING TWO DOSES OF THE VACCINE AGAINST SARS-COV-2 |
| title | PB2159: CHARACTERIZATION OF THE IMMUNE RESPONSE DEVELOPED IN PATIENTS WITH MULTIPLE MYELOMA AFTER RECEIVING TWO DOSES OF THE VACCINE AGAINST SARS-COV-2 |
| title_full | PB2159: CHARACTERIZATION OF THE IMMUNE RESPONSE DEVELOPED IN PATIENTS WITH MULTIPLE MYELOMA AFTER RECEIVING TWO DOSES OF THE VACCINE AGAINST SARS-COV-2 |
| title_fullStr | PB2159: CHARACTERIZATION OF THE IMMUNE RESPONSE DEVELOPED IN PATIENTS WITH MULTIPLE MYELOMA AFTER RECEIVING TWO DOSES OF THE VACCINE AGAINST SARS-COV-2 |
| title_full_unstemmed | PB2159: CHARACTERIZATION OF THE IMMUNE RESPONSE DEVELOPED IN PATIENTS WITH MULTIPLE MYELOMA AFTER RECEIVING TWO DOSES OF THE VACCINE AGAINST SARS-COV-2 |
| title_short | PB2159: CHARACTERIZATION OF THE IMMUNE RESPONSE DEVELOPED IN PATIENTS WITH MULTIPLE MYELOMA AFTER RECEIVING TWO DOSES OF THE VACCINE AGAINST SARS-COV-2 |
| title_sort | pb2159: characterization of the immune response developed in patients with multiple myeloma after receiving two doses of the vaccine against sars-cov-2 |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428916/ http://dx.doi.org/10.1097/01.HS9.0000975396.12745.cc |
| work_keys_str_mv | AT perezlaura pb2159characterizationoftheimmuneresponsedevelopedinpatientswithmultiplemyelomaafterreceivingtwodosesofthevaccineagainstsarscov2 AT soleramiriam pb2159characterizationoftheimmuneresponsedevelopedinpatientswithmultiplemyelomaafterreceivingtwodosesofthevaccineagainstsarscov2 AT coronamagdalena pb2159characterizationoftheimmuneresponsedevelopedinpatientswithmultiplemyelomaafterreceivingtwodosesofthevaccineagainstsarscov2 AT torresmontserrat pb2159characterizationoftheimmuneresponsedevelopedinpatientswithmultiplemyelomaafterreceivingtwodosesofthevaccineagainstsarscov2 AT casadoguiomar pb2159characterizationoftheimmuneresponsedevelopedinpatientswithmultiplemyelomaafterreceivingtwodosesofthevaccineagainstsarscov2 AT sanchezmenendezclara pb2159characterizationoftheimmuneresponsedevelopedinpatientswithmultiplemyelomaafterreceivingtwodosesofthevaccineagainstsarscov2 AT zurdoalejandro pb2159characterizationoftheimmuneresponsedevelopedinpatientswithmultiplemyelomaafterreceivingtwodosesofthevaccineagainstsarscov2 AT garciajavier pb2159characterizationoftheimmuneresponsedevelopedinpatientswithmultiplemyelomaafterreceivingtwodosesofthevaccineagainstsarscov2 AT murcianomariaaranzazu pb2159characterizationoftheimmuneresponsedevelopedinpatientswithmultiplemyelomaafterreceivingtwodosesofthevaccineagainstsarscov2 AT perezmariateresa pb2159characterizationoftheimmuneresponsedevelopedinpatientswithmultiplemyelomaafterreceivingtwodosesofthevaccineagainstsarscov2 AT gutierrezvalentingarcia pb2159characterizationoftheimmuneresponsedevelopedinpatientswithmultiplemyelomaafterreceivingtwodosesofthevaccineagainstsarscov2 AT coirasmariateresa pb2159characterizationoftheimmuneresponsedevelopedinpatientswithmultiplemyelomaafterreceivingtwodosesofthevaccineagainstsarscov2 AT morasararodriguez pb2159characterizationoftheimmuneresponsedevelopedinpatientswithmultiplemyelomaafterreceivingtwodosesofthevaccineagainstsarscov2 |